Brief: Sernova and JDRF to fund joint research to advance human clinical trials for treatment of hypoglycemic unawareness patients
12/07/2016 11:11
July 12 (Reuters) - Sernova Corp SVA.V
* Sernova and JDRF announce funding of joint research
collaboration to advance human clinical trials for treatment of
hypoglycemic unawareness patients with severe type
1 diabetes.
* Says JDRF will provide Sernova up to $2.45 million USD to
support a clinical trial at a major transplantation center in
United States
Source text for Eikon: ID:nMKW205ska
Further company coverage: SVA.V
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on Sernova Biotherapeutics
See all newsBrief: Seraxis And Sernova Announce Appointment Of Former FDA Medical Officer Dr. Patricia Beaston As Chief Medical Officer Of Seraxis And Post Merger Betanova Biotherapeutics
Brief: Sernova Appoints Jonathan Rigby As Interim Chair
Brief: Sernova Biotherapeutics Provides Positive Interim Data From Ongoing Phase 1/2 Clinical Trial Of Cell Pouch Bio-Hybrid Organ In Patients Living With Type 1 Diabetes
Brief: Sernova Biotherapeutics Secures $4 Million Loan To Further Advance Its Clinical Development Plans
Brief: Sernova Biotherapeutics Inc Study Is On Track To Meet Key Clinical Trial Endpoints